| 1 |
Vicentini C, Zotti CM, Cornio AR, Garlasco J, Marengo N, Meddis D, Ditommaso S, Giacomuzzi M, Memoli G, Bordino V, Gianino MM, On Behalf Of The Collaborating Group. Serological Responses up to 9 Months following COVID-19 mRNA Vaccination in Residents and Health-Care Workers of Long-Term Care Facilities: A Multicenter Prospective Cohort Study in Northern Italy. Vaccines (Basel) 2022;10. [PMID: 36560593 DOI: 10.3390/vaccines10122183] [Reference Citation Analysis]
|
| 2 |
Salvadori M. What Is New in Prophylaxis and Treatment of COVID-19 in Renal Transplant Patients? A Report from an ESOT Meeting on the Topic. Transplantology 2022;3:288-306. [DOI: 10.3390/transplantology3040030] [Reference Citation Analysis]
|
| 3 |
Nathanielly de Lima Silva, Danilo Nobre, Joyceane Alves de Oliveira, Márcia Santos Rezende, Joyce Thayane da Conceição dos Santos, Adriano Antunes de Souza Araújo, Lucindo José Quintans-Júnior, Rafael Ciro Marques Cavalcante, Luiz Carlos de Souza Ferreira, Paulo Ricardo Martins-Filho, Dulce Marta Schimieguel. Kinetics of humoral immune response in patients with asymptomatic or mild COVID-19: a longitudinal study based in an in-house indirect ELISA method. EXCLI J 2022;21. [PMID: 36381645 DOI: 10.17179/excli2022-5337] [Reference Citation Analysis]
|
| 4 |
Nakamura N, Park H, Kim KS, Sato Y, Jeong YD, Iwanami S, Fujita Y, Zhao T, Tani Y, Nishikawa Y, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Aihara K, Iwami S, Tsubokura M. A personalized antibody score for predicting individual COVID-19 vaccine-elicited antibody levels from basic demographic and health information.. [DOI: 10.1101/2022.07.05.22277283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Braeye T, Catteau L, Brondeel R, van Loenhout JAF, Proesmans K, Cornelissen L, Van Oyen H, Stouten V, Hubin P, Billuart M, Djiena A, Mahieu R, Hammami N, Van Cauteren D, Wyndham-Thomas C. Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021. Vaccine 2022:S0264-410X(22)00441-8. [PMID: 35459558 DOI: 10.1016/j.vaccine.2022.04.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
